Interpretation of p53 immunoreactivity in endometrial carcinoma: Establishing a clinically relevant cut-off level

Journal article

Peer reviewed

Abdulmohsen Alkushi, Peter Lim, Andrew Coldman, David Huntsman, Dianne Miller and C. Blake Gilks

International journal of gynecological pathology, Vol.23(2), pp.129-137

04/2004

PMID: 15084841

Abstract

Biological and medical sciences

Gynecology. Andrology. Obstetrics

Medical sciences

1 Record Views

Title: Interpretation of p53 immunoreactivity in endometrial carcinoma: Establishing a clinically relevant cut-off level
Creators - without role: Abdulmohsen Alkushi - BC Cancer Agency
Peter Lim - Departments of Radiation Oncology, British Columbia Cancer Agency, Vancouver BC, Canada
Andrew Coldman - Population and Preventive Oncology, British Columbia Cancer Agency, Vancouver BC, Canada
David Huntsman - University of British Columbia
Dianne Miller - Gynecology Tumor Group, British Columbia Cancer Agency, Vancouver BC, Canada
C. Blake Gilks - University of British Columbia
Publication Details: International journal of gynecological pathology, Vol.23(2), pp.129-137
Publisher: Lippincott
Identifiers: 9921467708331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article